ISSN: 2278-0238

Revue internationale de recherche et développement en pharmacie et sciences de la vie

Accès libre

Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Abstrait

EFFECT OF ZINC OXIDE NANOPARTICLES ON CANDIDA ALBICANS OF HUMAN SALIVA (IN VITRO STUDY)

Suha T Abd, Abbas F Ali

The potential use of zinc oxide and other metal oxide nanoparticles in biomedical are gaining interest in the scientific and medical communities, largely due to the physical and chemical properties of these nanoparticles, therefore there is an urgent need to develop new classes of antimicrobial agents, and recent studies demonstrate that hold a considerable promises. Candida albicans were isolated from saliva of forty eight volunteers of both sexes their age range between 18-22 years and then purified and diagnosed according to morphological characteristic and biochemical tests. Different concentrations of ZnO NPs were prepared from the stock solution; all the experiments were conducted in vitro. Disk diffusion method was used to study the sensitivity of Candida albicans to different concentrations of zinc oxide nanoparticles in comparison to effect of de-ionized water. Candida albicans were sensitive to all concentrations (0.01, 0.05, 0.1, 0.5, 1, 3 and 5.8) mg / ml of the zinc oxide nanoparticles solution in comparison to de-ionized water, revealing a highly significant difference in all concentrations.
This study revealed that zinc oxide nanoparticles were effective against Candida albicans.